» Articles » PMID: 23921962

Cell Surface Sialic Acid Modulates Extracellular Matrix Adhesion and Migration in Pancreatic Adenocarcinoma Cells

Overview
Journal Pancreas
Specialty Gastroenterology
Date 2013 Aug 8
PMID 23921962
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Tumor cells modulate their extracellular matrix (ECM) adhesion and migration to become more metastatic. Moreover, they show an increase in sialic acid, which could have an effect on their ECM adhesion and migration. This work describes the influence of pancreatic adenocarcinoma cell surface α2,3- and α2,6-sialic acid determinants on the aforementioned processes.

Methods: We have characterized the cell surface α2,3- and α2,6-sialic acids, and sialyl-Lewis x levels and the integrin levels of 2 pancreatic adenocarcinoma cell lines, Capan-1 and MDAPanc-28, grown at different cell densities, and also of the ST3Gal III overexpressing Capan-1 cells, C31. We have measured their adhesion to several ECM proteins and their migration through collagen with and without blocking their sialic acid determinants.

Results: Adhesion to ECM proteins of Capan-1 and MDAPanc-28 grown at different cell densities, and of C31, depended on their cell surface sialic acid determinants repertoire, correlating the higher α2,6-sialic acid levels with their increased ECM adhesion. Cell migration also depended on their sialic acid determinants expression; and in this case, higher α2,3-sialic acid levels correlated with a more migratory phenotype.

Conclusion: This study shows how the intrinsic heterogeneity of cell membrane sialylation regulates the adhesive and migratory potential of pancreatic adenocarcinoma cells.

Citing Articles

When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression.

Habeeb I, Alao T, Delgado D, Buffone Jr A Front Oncol. 2024; 14:1487306.

PMID: 39628991 PMC: 11611868. DOI: 10.3389/fonc.2024.1487306.


Cell Membrane Sialome: Sialic Acids as Therapeutic Targets and Regulators of Drug Resistance in Human Cancer Management.

Jastrzab P, Narejko K, Car H, Wielgat P Cancers (Basel). 2023; 15(20).

PMID: 37894470 PMC: 10604966. DOI: 10.3390/cancers15205103.


Glycation Interferes with the Activity of the Bi-Functional UDP--Acetylglucosamine 2-Epimerase/-Acetyl-mannosamine Kinase (GNE).

Hagenhaus V, Lopez J, Rosenstengel R, Neu C, Hackenberger C, Celik A Biomolecules. 2023; 13(3).

PMID: 36979358 PMC: 10046061. DOI: 10.3390/biom13030422.


Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy.

Li Y, Zhang Y, Tao Y, Huang X, Yu C, Xu H Stem Cells Int. 2023; 2023:1655750.

PMID: 36814525 PMC: 9940976. DOI: 10.1155/2023/1655750.


Sialyltransferase Inhibitor Ac3FNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice.

Miro L, Lopez J, Guerrero P, Martinez-Bosch N, Manero-Ruperez N, Moreno M Cancers (Basel). 2022; 14(24).

PMID: 36551619 PMC: 9776040. DOI: 10.3390/cancers14246133.